ADARx Pharmaceuticals, Inc. (ADRX) — Insider Trading
Insider trading activity for ADARx Pharmaceuticals, Inc. sourced from SEC EDGAR Form 4 filings.
Overview
- Total insider trades: 94
- Last trade date: Sep 30, 2026
- Ticker: ADRX
Top Insiders
- Ackles Robert William (Chief People Officer) — 1 trades, buy: $0, sell: $0
- Fisk Ryan (CFO and CBO) — 1 trades, buy: $0, sell: $0
- Zhu Rui (NMN) (Chief Technology Officer) — 1 trades, buy: $0, sell: $0
- MacLeod Alan Robert (Chief Scientific Officer) — 1 trades, buy: $0, sell: $0
- Li Zhen (President and CEO) — 1 trades, buy: $0, sell: $0
Recent Trades
| Date | Insider | Ticker / Company |
Type | Shares | Value |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
256,448 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
513,067 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
1,333,975 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
7,127,019 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
564,187 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
769,601 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
2,000,962 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
10,690,530 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
BUY |
588,235 |
$10.0M |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
BUY |
61,516 |
$1.0M |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
256,448 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
513,067 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
1,333,975 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
7,127,019 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
BUY |
300,249 |
$5.1M |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
564,187 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
769,601 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
2,000,962 |
N/A |
| Sep 28, 2026 |
ORBIMED ADVISORS LLC |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
10,690,530 |
N/A |
| Sep 28, 2026 |
GORDON CARL L |
ADRX ADARx Pharmaceuticals, Inc. |
OTHER |
256,448 |
N/A |
← All companies · Full trades feed
